Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Practice Guidelines – Small-Cell Lung Cancer

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 

Published in 2021 - Ann Oncol (2021)
Authors: A-M.C. Dingemans, M. Früh, A. Ardizzoni, B. Besse, C. Faivre-Finn, L.E. Hendriks, S. Lantuejoul, S. Peters, N. Reguart, C.M. Rudin, D. De Ruysscher, P.E. Van Schil, J. Vansteenkiste & M. Reck, on behalf of the ESMO Guidelines Committee

  • This ESMO Clinical Practice Guideline provides key recommendations for managing SCLC
  • It covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up
  • Treatment algorithms for locoregional, advanced/metastatic and recurrent SCLC are provided
  • All recommendations were compiled by a multidisciplinary group of experts
  • Recommendations are based on available scientific data and the authors’ collective expert opinion

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.